Sign In
Buy LIXT
$7.30
-0.180 (-2.41%)
At Close: Jun 23, 2026
LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
08:30am, Monday, 26'th Feb 2024
Agreement Focuses on Combining LIXTE's LB-100 with Various Innovative Cancer Immunotherapies PASADENA, CA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW)
First Patient Dosed with LIXTE's LB-100 and GSK's Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial
08:30am, Monday, 29'th Jan 2024
PASADENA, CA, Jan. 29, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”), today announced the dosing of the first patient in a Pha
LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations
08:30am, Monday, 13'th Nov 2023
PASADENA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing
LIXTE Biotechnology Holdings Announces the Passing of its Founder, John S. Kovach
08:30am, Monday, 09'th Oct 2023
PASADENA, CA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage biotechnology company developing a nove
LIXTE Appoints Bas van der Baan as President and Chief Executive Officer
08:30am, Tuesday, 26'th Sep 2023
Biotechnology V eteran Bas van der Baan B rings P recision O ncology E xpertise ; Founder John S . Kovach Named Executive Chairman
The Phase 1b Clinical Trial Focuses on Assessing the Safety and Efficacy of the Two-Drug Combination in a Cancer Associated with Longer Survival to Immunotherapy When Genetically Deficient in PP2A
PASADENA, CA, July 20, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced the closing of its previously announced
How to Sustainably Invest in Penny Stocks
06:00am, Monday, 13'th Feb 2023
Here's some tips for sustainably investing in penny stocks The post How to Sustainably Invest in Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is Lixte Biotech (LIXT) Stock Down 29% Today?
08:54am, Wednesday, 08'th Feb 2023
Lixte Biotech (NASDAQ: LIXT ) stock is dropping on Wednesday but it's not due to any negative news from the drug discovery company. Instead, it's the result of shares retreating after a massive rally
Can Trading Penny Stocks Be a Full Time Job?
06:00am, Wednesday, 08'th Feb 2023
Are penny stocks able to provide full time income? The post Can Trading Penny Stocks Be a Full Time Job?
LIXTE Biotechnology Holdings to Present at Planet MicroCap Showcase: VIRTUAL 2022 Investor Conference
08:05am, Wednesday, 30'th Nov 2022
Presentation to be Broadcast Wednesday December 7 at 3:30 p.m. EST/12:30 p.m.
PASADENA, CA, Oct. 13, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), (“LIXTE” or the “Company”), a clinical-stage pharmaceutical company focused on developing an
Short Squeeze Stocks: RDBX, MDVL and 3 Others Experts Think Are Ready to Pop
12:18pm, Monday, 09'th May 2022
Short squeeze stocks are in focus today following another bearish week for the markets. Here are Fintel's top short squeeze candidates.
Trending Penny Stocks to Watch As the First Week of May Ends
06:16pm, Thursday, 05'th May 2022
Are these trending penny stocks on your watchlist in May? The post Trending Penny Stocks to Watch As the First Week of May Ends appeared first on Penny Stocks to Buy, Picks, News and Information | P
Short Squeeze Stocks: HCDI, ZYME and 3 Others Experts Think Are Ready to Pop
11:22am, Monday, 02'nd May 2022
Short squeeze stocks are once again in focus this week as Fintel released its weekly Short Squeeze Leaderboard report. Let's take a look.
